intermediatedonepeziloxybutyninanticholinergicpolypharmacydementiageriatric
A 74-year-old male on donepezil for mild Alzheimer's dementia presents with new urinary incontinence. His PCP started oxybutynin 5 mg last week. His daughter reports he has become more confused since starting the new medication. Which assessment finding is MOST clinically significant?